MitochondrialModerate Evidence

SS-31

Also known as: Elamipretide, Bendavia, MTP-131

Mitochondria-targeted peptide that repairs inner mitochondrial membrane and restores energy production.

Benefits

6

Conditions

6

Evidence

Multiple Phase II clinical trials, preclinical studies+ studies

Source

Synthetic mitochondria-targeted peptide

Overview

Mitochondria-targeted peptide that repairs inner mitochondrial membrane and restores energy production.

Mechanism of Action

Selectively binds cardiolipin on inner mitochondrial membrane, stabilizes electron transport chain complexes, restores ATP production efficiency, reduces oxidative stress and ROS, eliminates dysfunctional mitochondria while preserving healthy ones, restores redox balance.

Key Benefits

  • Restores mitochondrial energy production
  • Reduces oxidative damage
  • Improves exercise capacity
  • Protects against age-related energy decline
  • Cardiovascular protection
  • Neurodegenerative disease prevention

Clinical Applications

Mitochondrial disordersHeart failureAge-related energy declineNeurodegenerative diseasesIschemia-reperfusion injuryBarth syndrome

Dosing Guidelines

Intravenous infusion

Typical DoseClinical trials used 0.25-4 mg/kg
FrequencyDaily
DurationVariable per condition

Subcutaneous injection

Typical Dose5-40 mg
FrequencyDaily
DurationResearch protocols vary

* Dosing should be individualized. Always consult with a qualified healthcare practitioner.

Research & Evidence

Evidence Level
Moderate
Studies

Multiple Phase II clinical trials, preclinical studies

Summary

Clinical trials in heart failure and mitochondrial disorders. FDA Fast Track designation for Barth syndrome. Strong preclinical evidence for mitochondrial repair. Promising human safety and efficacy data.

Safety Information

Potential Side Effects

  • Minimal in trials
  • Injection site reactions
  • Headache

Contraindications

  • Pregnancy
  • Breastfeeding

Interactions

  • None well-documented

Quick Facts

CategoryMitochondrial
SourceSynthetic mitochondria-targeted peptide
Legal StatusInvestigational drug, Phase II/III trials ongoing
Gabriel Brain Score
88/ 100

Source Your Protocol

Our preferred peptide partner offers lab-tested, COA-verified peptides with optional physician oversight. Sourced from US-regulated facilities.